140 likes | 406 Views
PneumoniaCheck. David N. Ku, MD, PhD Regents ’ Professor and L.P. Huang Chair Prof Engineering Entrepreneurship Larry Anderson, Jonas Wenchel - CDC. Georgia Institute of Technology Disclosure: Company ownership. Pneumonia. Infection of the lungs #1 cause of death in children worldwide.
E N D
PneumoniaCheck David N. Ku, MD, PhD Regents’ Professor and L.P. Huang Chair Prof Engineering Entrepreneurship Larry Anderson, Jonas Wenchel - CDC Georgia Institute of Technology Disclosure: Company ownership
Pneumonia Infection of the lungs #1 cause of death in children worldwide
Current situation • Pneumonia kills1,000 children daily in rural India • Limited availability and accessibility of diagnostics • 80% undiagnosed with current methods
Gates Foundation • Grand Challenge • Pneumonia • TB - Tuberculosis • LRTI – Lower Respiratory Tract Infection • Airborne contagious disease • SuperSpreaders
Problem - Sampling • Current diagnosis uses mouth and nose samples • Normal mouths have pneumococcus • Specimens contaminated • Many false positives
Bronchoalveolar Lavage (BAL) Current method to get a lung sample Isolated treatment for antibiotic therapy
Solution - PneumoniaCheck™ PneumoniaCheck™ uses fluid mechanics to isolate lung pathogens onto filter
Analysis • Microbiology- Traditional culture methods • DNA Polymerase Chain Reaction (PCR)- Highly sensitive- Identifies multiple pathogens simultaneously- Rapid turnaround (<24 hours)
Huge unaddressed market • Patent pending, disruptive technology • Good Manufacturing Practices - FDA cleared medical device • Expanding indications • Distribution and Sales
Addressable Market Size Target hospitals, make standard Florida 105,000 Cases $10.5 million United States 5,600,000 cases $560 million Atlanta 9,500 Cases $900,000 Texas 110,000 Cases $11 million http://www.ahd.com/state_statistics.html
Better Medicine: • PneumoniaCheck™ selectively collects from lungs • Broad-spectrum antibiotics reduced • Hospital stay shortened, less complications • Save approximately $1,000 per patient • Triple Bottom Line Company